McCall M R, La Belle M, Forte T M, Krauss R M, Takanami Y, Tribble D L
Department of Molecular and Nuclear Medicine, Life Sciences Division, Ernest Orlando Lawrence Berkeley National Laboratory, Donner Laboratory, University of California, Berkeley, CA 94720, USA.
Biochim Biophys Acta. 1999 Jan 29;1437(1):23-36. doi: 10.1016/s0005-2760(98)00177-5.
Platelet-activating factor acetylhydrolase (PAF-AH) is transported by lipoproteins in plasma and is thought to possess both anti-inflammatory and anti-oxidative activity. It has been reported that PAF-AH is recovered primarily in small, dense LDL and HDL following ultracentrifugal separation of lipoproteins. In the present studies, we aimed to further define the distribution of PAF-AH among lipoprotein fractions and subfractions, and to determine whether these distributions are affected by the lipoprotein isolation strategy (FPLC versus sequential ultracentrifugation) and LDL particle distribution profile. When lipoproteins were isolated by FPLC, the bulk (approximately 85%) of plasma PAF-AH activity was recovered within LDL-containing fractions, whereas with ultracentrifugation, there was a redistribution to HDL (which contained approximately 18% of the activity) and the d>1.21 g/ml fraction (which contained approximately 32%). Notably, re-ultracentrifugation of isolated LDL did not result in any further movement of PAF-AH to higher densities, suggesting the presence of dissociable and nondissociable forms of the enzyme on LDL. Differences were noted in the distribution of PAF-AH activity among LDL subfractions from subjects exhibiting the pattern A (primarily large, buoyant LDL) versus pattern B (primarily small, dense LDL) phenotype. In the latter group, there was a relative depletion of PAF-AH activity in subfractions in the intermediate to dense range (d=1.039-1.047 g/ml) with a corresponding increase in enzyme activity recovered within the d>1.21 g/ml ultracentrifugal fraction. Thus, there appears to be a greater proportion of the dissociable form of PAF-AH in pattern B subjects. In both populations, most of the nondissociable activity was recovered in a minor small, dense LDL subfraction. Based on conjugated dienes as a measure of lipid peroxidation, variations in PAF-AH activity appeared to contribute to variations in oxidative behavior among ultracentrifugally isolated LDL subfractions. The physiologic relevance of PAF-AH dissociability and the minor PAF-AH-enriched oxidation-resistant LDL subpopulation remains to be determined.
血小板活化因子乙酰水解酶(PAF-AH)在血浆中由脂蛋白转运,被认为具有抗炎和抗氧化活性。据报道,在脂蛋白超速离心分离后,PAF-AH主要在小而密的低密度脂蛋白(LDL)和高密度脂蛋白(HDL)中回收。在本研究中,我们旨在进一步确定PAF-AH在脂蛋白组分和亚组分中的分布,并确定这些分布是否受脂蛋白分离策略(快速蛋白质液相色谱法(FPLC)与连续超速离心法)和LDL颗粒分布谱的影响。当通过FPLC分离脂蛋白时,大部分(约85%)血浆PAF-AH活性在含LDL的组分中回收,而通过超速离心法时,活性重新分布到HDL(其含有约18%的活性)和密度大于1.21 g/ml的组分(其含有约32%)。值得注意的是,对分离出的LDL进行再次超速离心并未导致PAF-AH向更高密度的进一步移动,这表明LDL上存在可解离和不可解离形式的该酶。在表现出A型(主要是大的、漂浮的LDL)与B型(主要是小的、致密的LDL)表型的受试者的LDL亚组分中,PAF-AH活性分布存在差异。在后一组中,中间至致密范围(密度=1.039 - 1.047 g/ml)的亚组分中PAF-AH活性相对减少,而在密度大于1.21 g/ml的超速离心组分中回收的酶活性相应增加。因此,B型受试者中PAF-AH的可解离形式比例似乎更大。在这两个人群中,大部分不可解离活性在一个较小的小而密的LDL亚组分中回收。以共轭二烯作为脂质过氧化的指标,PAF-AH活性的变化似乎导致了超速离心分离的LDL亚组分之间氧化行为的差异。PAF-AH可解离性和富含PAF-AH且抗氧化的少量LDL亚群的生理相关性仍有待确定。